About usSign in
Status
ACTIVE
Global HQ
California, United States
Countries of investment
  • USA
Investment stages
  • Seed
Industries
  • Biotech
  • Health & Hospital Services
  • Digital Health
  • Health It
  • -
About
BioVerge is a platform enabling investment in healthcare startups. They leverage deep domain expertise and proprietary deal access to drive compelling riskadjusted returns.
Min check size
$100K
Max check size
$2M
Fund size
NPS

Investment Thesis

BioVerge focuses on investing in healthcare startups that are poised to transform the industry. They provide individuals access to highcaliber investment opportunities typically reserved for institutions.
Lead investor
Co Invest
Number of exits
Preferred contact method

Team

Executive Team:

Neil J. Littman: Founder

Chief Executive Officer

Managing Director

Rick Gibb: Founder

Chief Operating Officer

Managing Director

Advisors:

Sonia Arrison: Venture Partner

Portfolia; Founder

100 Plus Capital; Board Chair

The Alliance for Longevity Initiatives

Brenden Boot

M.D.: Neurologist

Brigham and Women's Hospital; Assistant Professor

Harvard Medical School

Mark Chao

Ph.D.: Cofounder and CEO

TenSixteen

Dave Chisholm: Partner Manager

Dassault Systèmes

Kevin Coker

JD

MPH

MS: Cofounder & CEO

Proxima Clinical Research

Curt Herberts: President & COO

Kriya Therapeutics

Brock Reeve

Ph.D.: Cofounder & CEO

Eos BioInnovation; Executive Director

Harvard Stem Cell Institute

Greg Simon: Biden Cancer Initiative; Executive Director

White House Cancer Moonshot Task Force

David Stubbs: Head of European Health Care

Raymond James Financial International

Ltd.

Joseph Wu

M.D. Ph.D.: Professor & Director

Stanford Cardiovascular Institute; PresidentElect

American Heart Association; Cofounder

Greenstone Biosciences

Portfolio

Ancilla

Alto Neuroscience

Aspen Neuroscience

Bionaut Labs

Biobot Analytics

BioRosa Technologies

BioIntelliSense

Circularis

CrowdMed

ContraLine

ECHO Labs

EnClear Therapies

Excision BioTherapeutics

Elucid Bioimaging

Enveda Biosciences

Eigen Therapeutics

Foresight Diagnostics

GigaMune

HepaTx

Intelligent Implants

IVIVA Medical

Juno Bio

JelikaLite

Leucadia Therapeutics

LISCure Biosciences

Modulo

Notable Labs

NutriSense

Octagon Therapeutics

Octant

Ombre

Ochre Bio

Pragma Therapeutics

Repair Biotechnologies

RockStep Solutions

Suggestic

Vaxess Technologies

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp